Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$1.98 -0.08 (-3.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Cash & Current Investments (2020 - 2026)

Updated

Acumen Pharmaceuticals' Cash & Current Investments came in at $110.2 million for Q2 2026, down 23.1% from $143.37 million a year earlier and down 14.2% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals' Cash & Current Investments was $116.87 million, down 31.9% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $171.56 million in FY2024 (-29.6%), $243.52 million in FY2023 (+37.1%), $177.61 million in FY2022 (-8.6%) and $194.24 million in FY2021 (+343.7%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q2 2021.
  • Year-over-year, Cash & Current Investments has declined for eight consecutive quarters, with an average decline of 28.5% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 343.7%), and the weakest in Q2 2025 (a decline of 45.0%).
  • Business Quant data shows ABOS's Cash & Current Investments at $128.4 million (Q1 2026), $116.87 million (Q4 2025) and $126.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Acumen Pharmaceuticals 143.18 Mn -338.89 Mn - 110.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 110.20 Mn
Mar 31, 2026 128.40 Mn
Dec 31, 2025 116.87 Mn
Sep 30, 2025 126.61 Mn
Jun 30, 2025 143.37 Mn
Mar 31, 2025 149.15 Mn
Dec 31, 2024 171.56 Mn
Sep 30, 2024 200.34 Mn
Jun 30, 2024 260.47 Mn
Mar 31, 2024 252.51 Mn
Dec 31, 2023 243.52 Mn
Sep 30, 2023 215.43 Mn
Jun 30, 2023 144.88 Mn
Mar 31, 2023 140.41 Mn
Dec 31, 2022 177.61 Mn
Sep 30, 2022 200.19 Mn
Jun 30, 2022 189.91 Mn
Mar 31, 2022 189.09 Mn
Dec 31, 2021 194.24 Mn
Sep 30, 2021 199.96 Mn
API Access

Acumen Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABOS&period=max&api_key=YOUR_API_KEY